O-GLCNACYLATION IS NOT INCREASED IN THE HYPOTHALAMUS OF RATS GIVEN 6 WEEK ACCESS TO SUCROSE SOLUTION DESPITE MARKERS OF METABOLIC DYSREGULATION
dc.contributor.advisor | Castonguay, Thomas W | en_US |
dc.contributor.author | Hudgins, Samantha Morgan | en_US |
dc.contributor.department | Nutrition | en_US |
dc.contributor.publisher | Digital Repository at the University of Maryland | en_US |
dc.contributor.publisher | University of Maryland (College Park, Md.) | en_US |
dc.date.accessioned | 2019-02-05T06:32:14Z | |
dc.date.available | 2019-02-05T06:32:14Z | |
dc.date.issued | 2018 | en_US |
dc.description.abstract | The peptide hormone leptin acts globally to maintain various metabolic processes. Impaired response to leptin binding is referred to as leptin resistance and results in metabolic dysregulation. Leptin is essential in the prevention of weight gain through central signals to increase energy expenditure and reduce food intake. A sugar sensitive pathway, the hexosamine biosynthesis pathway (HBP), may be the cause of diet induced leptin resistance. The HBP glycosylates proteins by modifying fructose- 6-phosphate molecules from glycolysis. While high sugar diets have been linked to leptin resistance, O-GlcNAcylation of pathway proteins have not been examined. Approximately 8-week-old male rats were assigned to ad libitum access to diet and water or 30% sucrose solution, diet and water. On Day 5 rats were surgically fitted with a third ventricle cannula. On Day 41, diet and sugar solutions were removed for an overnight fast. On Day 42 each rat received a central injection of leptin or control solution and subsequently euthanized 30 minutes post injection. Body weight and body composition were not significantly different between treatment groups after 42 days. However, the Sucrose group exhibited signs of metabolic syndrome, evidenced by increased fasting serum triglycerides and glucose as well as decreased serum HDL. Analysis of hypothalamic O-GlcNAcylation revealed no significant difference between treatment groups. These data may be the result of variability of glucose utilization within the hypothalamus. These data support previous findings that 42-day access to a 30% sucrose solution yields evidence of metabolic syndrome in the absence of obesity as well as the absence of increased hypothalamic OGlcNAcylation. Future research should examine O-GlcNAcylation regionally within the hypothalamus. Analysis of protein specific O-GlcNAcylation was not achieved; however, a novel O-GlcNAcylation was observed in hypothalamic tissue at the Threonine 1808 residue of prolow-density lipoprotein receptor-related protein 1 isoform X1 (LRP-1), a protein that may play a crucial role in leptin signaling. These data give further evidence to support the use of 30% sucrose solution to model leptin resistance in Sprague Dawley rats, as well as provide a target protein for future analysis. | en_US |
dc.identifier | https://doi.org/10.13016/mvtp-ndzh | |
dc.identifier.uri | http://hdl.handle.net/1903/21683 | |
dc.language.iso | en | en_US |
dc.subject.pqcontrolled | Nutrition | en_US |
dc.subject.pquncontrolled | Cannulation | en_US |
dc.subject.pquncontrolled | Hypothalamus | en_US |
dc.subject.pquncontrolled | Leptin | en_US |
dc.subject.pquncontrolled | Metabolism | en_US |
dc.subject.pquncontrolled | Obesity | en_US |
dc.subject.pquncontrolled | Sucrose | en_US |
dc.title | O-GLCNACYLATION IS NOT INCREASED IN THE HYPOTHALAMUS OF RATS GIVEN 6 WEEK ACCESS TO SUCROSE SOLUTION DESPITE MARKERS OF METABOLIC DYSREGULATION | en_US |
dc.type | Dissertation | en_US |
Files
Original bundle
1 - 1 of 1